Sign in

CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company

BioRestorative Therapies, Inc.

Sign in to watch
Ticker
BRTX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
301341024
Phone
(631) 760-8100
Business address
40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
Former names
Stem Cell Assurance, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-03-25 Weinreb Mark CEO and Chairman of the Board Returned to the company · Stock Option −20,000 0
2019-03-25 Weinreb Mark CEO and Chairman of the Board Grant or award · Stock Option +20,000 20,000
2019-03-25 Weinreb Mark CEO and Chairman of the Board Returned to the company · Stock Option −12,500 0
2019-03-25 Weinreb Mark CEO and Chairman of the Board Grant or award · Stock Option +12,500 12,500
2019-03-25 Weinreb Mark CEO and Chairman of the Board Returned to the company · Stock Option −50,000 0
2019-03-25 Weinreb Mark CEO and Chairman of the Board Grant or award · Stock Option +50,000 50,000
2019-03-25 Weinreb Mark CEO and Chairman of the Board Returned to the company · Stock Option −150,000 0
2019-03-25 Weinreb Mark CEO and Chairman of the Board Grant or award · Stock Option +150,000 150,000
2019-03-25 Weinreb Mark CEO and Chairman of the Board Returned to the company · Stock Option −208,000 0
2019-03-25 Weinreb Mark CEO and Chairman of the Board Grant or award · Stock Option +208,000 208,000
2019-03-25 Weinreb Mark CEO and Chairman of the Board Returned to the company · Stock Option −275,000 0
2019-03-25 Weinreb Mark CEO and Chairman of the Board Grant or award · Stock Option +275,000 275,000
2019-03-25 Weinreb Mark CEO and Chairman of the Board Returned to the company · Stock Option −275,000 0
2019-03-25 Weinreb Mark CEO and Chairman of the Board Grant or award · Stock Option +275,000 275,000
2019-03-25 Weinreb Mark CEO and Chairman of the Board Returned to the company · Stock Option −275,000 0
2019-03-25 Weinreb Mark CEO and Chairman of the Board Grant or award · Stock Option +275,000 275,000
2019-03-25 ALSTODT LANCE EVP and Chief Strategy Officer Returned to the company · Stock Option −500,000 0
2019-03-25 ALSTODT LANCE EVP and Chief Strategy Officer Grant or award · Stock Option +500,000 500,000
2019-03-25 Clyde Mandy D. VP of Operations Returned to the company · Stock Option −4,000 0
2019-03-25 Clyde Mandy D. VP of Operations Grant or award · Stock Option +4,000 4,000

Page 18 of 35 · 690 trades